Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º 16Çü E7 Á¾¾ç ´Ü¹éÀÇ ÀλêÈ­¿¡ µû¸¥ Ç׿ø¼ºÀÇ º¯È­ Change of the Antigenecity of Human Papillomavirus Type 16 E7 Oncoprotein according to Phosphorylation

´ëÇѾÏÇÐȸÁö 1998³â 30±Ç 2È£ p.313 ~ 320
¼Ò¼Ó »ó¼¼Á¤º¸
¹Ú³ëÇö/Noh Hyun Park ±â¼±È£/³ëÁÖ¿ø/±èÀç¿ø/¼Û¿ë»ó/°­¼ø¹ü/ÀÌÈ¿Ç¥/Sun Ho Kee/Joo Won Noh/Jae Weon Kim/Yong Sang Song/Soon Beom Kang/Hyo Pyo Lee

Abstract

°á·Ð
º» ¿¬±¸¿¡¼­´Â E7ÀÇ ÀλêÈ­¿¡ µû¸¥ ¿µÇâ Áß Ç׿ø¼ºÀÇ º¯È­ ¿©ºÎ¸¦ Á¶»çÇÏ°íÀÚ ¿ì¼± Àλê
È­°¡ ÀÌ·ç¾îÁöÁö ¾ÊÀº ´ëÀå±Õ ¹ßÇö E7¿¡ ´ëÇØ ´ÜÁÖ Ç×ü¸¦ Á¦ÀÛÇÏ¿´°í °á¼Õ º¯Ã¼ Á¦ÀÛÀ»
ÅëÇØ ÀáÀçÀûÀÎ Ç׿ø¼º ºÎÀ§¸¦ °áÁ¤ÇÏ¿´À¸¸ç CK ¥±¸¦ »ç¿ëÇÑ in vitro ÀλêÈ­ ºÐ¼®°ú CK ¥±
ÀúÇØÁ¦ÀÎ DRB¸¦ ÀÌ¿ëÇÑ ½ÇÇèÀ» ÅëÇØ µÎ °¡Áö ´ÜÁÖ Ç×üÁß ÀλêÈ­°¡ ¿¹»óµÇ´Â ºÎÀ§¿Í ¹ÝÀÀ
ÇÏ´Â Ç×ü(IB10)°¡ E7 ´Ü¹éÀÌ ÀλêÈ­µÊÀ¸·Î½á Ç׿ø¼ºÀÌ °¨¼ÒµÈ´Ù´Â °ÍÀ» Áõ¸íÇÏ¿´´Ù. ÀÌ´Â
E7ÀÇ ÀλêÈ­¿¡ µû¶ó Ç׿ø¼º°ú °°Àº »ý¹°ÇÐÀû Ư¼º¿¡ ¿µÇâÀ» ÁÙ ¼ö ÀÖ´Ù´Â »ç½ÇÀ» º¸ÀÎ °Í
À¸·Î ÀÌ·¯ÇÑ ±â´ÉÀÇ º¯È­´Â Rb¿ÍÀÇ °áÇÕ ¶Ç´Â º°°³ÀÇ ±âÀüÀ» °ÅÃļ­ ÀڱðæºÎÀÇ ¾ÏÈ­°úÁ¤
¿¡ ÀÏÁ¤ÇÑ ¿µÇâÀ» ÁÙ °¡´É¼ºÀ» ½Ã»çÇÏ´Â ¼Ò°ßÀ¸·Î »ý°¢µÈ´Ù.

Purpose : It was suggested that immunogenic region of E7 proteins of human
papillo-mavirus (HPV) type 16 encompass casein kinase (CK) ¥± phosphorylation site
and the resulting negative charge may affect the various biologic function of E7 protein.
This study was undertaken to analyze the change of antigenic characteristics of HPV
type 16, E7 oncoprotein according to phosphorylation.
Materials and Methods : We produced two monoclonal antibodies (VD6 and IB10)
which showed different reactivities to E7 proteins expressed from bacteria or extracted
from CaSki cell. These reaction were analyzed by Western blotting. Also the antigenic
sites estimation of these antibodies using nested deletion sets was done. On the basis of
above experiments, we performed in vitro phosphorylation assay using CK ¥± and its
specific inhibitor, DRB (5, 6-dichloro-1-¥â-D-ribofuranosylbenzimidazole), to analyze the
IB10 reactivity to E7 oncoproteins according to phosphorylation.
Results : In Western blot analysis, VD6 and IB10 antibodies reacted strongly to
bacterially expressed 27 protein. But using E7 extracted from CaSki cell, VD6 reacted to
2.0 kDa E7 protein whereas IB10 showed weak reactivity. The antigenic sites estimation
of these antibodies showed that antigenic site of VD6 was located in amino terminal
region and that of IB10 in the middle portion in the range of approximate amino acid 25
¡­45. The antigenic site of IB10 might contain the possible phosphorylation sites
(Ser-31, 32) in E7. Considering this, the different reactivities of IB10 to E7 proteins
expressed in bacteria and extracted from CaSki cell might be due to phosphorylation. In
in vitro phosphorylation assay using CK ¥± the phosphorylation of E7 increased
according to reaction time. And this phosphorylation reduced the reactivity of IB10 to E7
protein whereas the reactivity of VD6 did not change. Also the reactivity of IB10 to E7
protein increased in a dose dependent manner with CK ¥± specific inhibitor, DRB treated
CaSki cell extracts.
Conclusion : These result showed the antigenecity is affected by the degree of
phosphorylation of E7 protein.

Å°¿öµå

HPV 16; E7; Phosphorylation; Antigenecity;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS